1. Home
  2. CRNX vs FICO Comparison

CRNX vs FICO Comparison

Compare CRNX & FICO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRNX
  • FICO
  • Stock Information
  • Founded
  • CRNX 2008
  • FICO 1956
  • Country
  • CRNX United States
  • FICO United States
  • Employees
  • CRNX N/A
  • FICO N/A
  • Industry
  • CRNX Biotechnology: Pharmaceutical Preparations
  • FICO Business Services
  • Sector
  • CRNX Health Care
  • FICO Consumer Discretionary
  • Exchange
  • CRNX Nasdaq
  • FICO Nasdaq
  • Market Cap
  • CRNX 2.8B
  • FICO 44.5B
  • IPO Year
  • CRNX 2018
  • FICO 1987
  • Fundamental
  • Price
  • CRNX $31.68
  • FICO $1,505.39
  • Analyst Decision
  • CRNX Strong Buy
  • FICO Buy
  • Analyst Count
  • CRNX 8
  • FICO 12
  • Target Price
  • CRNX $74.86
  • FICO $2,228.00
  • AVG Volume (30 Days)
  • CRNX 723.0K
  • FICO 341.1K
  • Earning Date
  • CRNX 08-07-2025
  • FICO 07-30-2025
  • Dividend Yield
  • CRNX N/A
  • FICO N/A
  • EPS Growth
  • CRNX N/A
  • FICO 21.78
  • EPS
  • CRNX N/A
  • FICO 23.21
  • Revenue
  • CRNX $760,000.00
  • FICO $1,840,361,000.00
  • Revenue This Year
  • CRNX $402.02
  • FICO $17.67
  • Revenue Next Year
  • CRNX $771.03
  • FICO $15.78
  • P/E Ratio
  • CRNX N/A
  • FICO $64.84
  • Revenue Growth
  • CRNX N/A
  • FICO 14.71
  • 52 Week Low
  • CRNX $24.10
  • FICO $1,484.29
  • 52 Week High
  • CRNX $62.53
  • FICO $2,402.52
  • Technical
  • Relative Strength Index (RSI)
  • CRNX 62.48
  • FICO 27.12
  • Support Level
  • CRNX $28.98
  • FICO $1,520.00
  • Resistance Level
  • CRNX $32.49
  • FICO $1,905.33
  • Average True Range (ATR)
  • CRNX 1.20
  • FICO 90.85
  • MACD
  • CRNX 0.43
  • FICO -33.97
  • Stochastic Oscillator
  • CRNX 94.31
  • FICO 6.10

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

About FICO Fair Isaac Corproation

Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's US-centric credit scores business accounts for most of the firm's profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.

Share on Social Networks: